Your browser doesn't support javascript.
loading
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.
Barba, M; Sperati, F; Stranges, S; Carlomagno, C; Nasti, G; Iaffaioli, V; Caolo, G; Mottolese, M; Botti, G; Terrenato, I; Vici, P; Serpico, D; Giordano, A; D'Aiuto, G; Crispo, A; Montella, M; Capurso, G; Delle Fave, G; Fuhrman, B; Botti, C; De Placido, S.
  • Barba M; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, Temple University, Philadelphia, USA.
Ann Oncol ; 23(7): 1838-45, 2012 Jul.
Article en En | MEDLINE | ID: mdl-22100694

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucemia / Neoplasias de la Mama / Neoplasias Colorrectales / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2012 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Glucemia / Neoplasias de la Mama / Neoplasias Colorrectales / Anticuerpos Monoclonales Humanizados / Anticuerpos Monoclonales / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2012 Tipo del documento: Article